Syncom Formulations (India) consolidated net profit declines 12.63% in the March 2024 quarter

Sales rise 22.29% to Rs 74.57 crore

Net profit of Syncom Formulations (India) declined 12.63% to Rs 7.40 crore in the quarter ended March 2024 as against Rs 8.47 crore during the previous quarter ended March 2023. Sales rose 22.29% to Rs 74.57 crore in the quarter ended March 2024 as against Rs 60.98 crore during the previous quarter ended March 2023.

For the full year,net profit rose 26.11% to Rs 25.31 crore in the year ended March 2024 as against Rs 20.07 crore during the previous year ended March 2023. Sales rose 17.45% to Rs 263.39 crore in the year ended March 2024 as against Rs 224.25 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales74.5760.98 22 263.39224.25 17 OPM %12.639.77 -11.258.75 - PBDT11.3311.44 -1 38.7031.10 24 PBT10.0310.27 -2 33.9726.56 28 NP7.408.47 -13 25.3120.07 26

Powered by Capital Market - Live News